In-Vivo Models of Arrhythmias: a Canine Model of Sudden Cardiac Death
KeywordsHeart Rate Variability Ventricular Fibrillation Susceptible Animal Left Circumflex Coronary Artery Great Cardiac Vein
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Billman GE (1989) The effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation. J Pharmacol Exp Therap 248: 1334–1342Google Scholar
- Billman GE, Hamlin RL (1996) The effects of a novel calcium channel antagonist, mibefradil, on refractory period and arrhythmias induced by programmed electrical stimulation and myocardial ischemia: a comparison with diltiazem and verapamil. J Pharmacol Exp Therap 277: 1517–1526Google Scholar
- Billman GE, Castillo LC, Hensley J, Hohl CM, Altschuld RA (1997) β2-adrenergic receptor antagonists protect against ventricular fibrillation: In vivo evidence and in vitro evidence for enhanced sensitivity to β2-adrenergic stimulation in animals susceptible to sudden death. Circulation 96: 1914–1922PubMedGoogle Scholar
- Billman GE, Englert HC, Schoelkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel; Part II: effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs. J Pharmacol Exp Therap 286: 1465–1473Google Scholar
- Collins MN, Billman GE (1989) Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation. Am J Physiol Heart Circ Physiol 257:H1886–H1894Google Scholar
- Davis HT, Decamilla J, Bayer LW, Moss AJ (1979) Survivorship patterns in the post hospital phase of myocardial infarction. Circulation 64: 1252–1258Google Scholar
- Gögelein H (2001) Inhibition of cardiac ATP-dependent potassium channels by sulfonylurea drugs. Curr Opin Invest Drugs 2: 71–80Google Scholar
- Houle MS, Billman GE (1999) Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am J Physiol Heart Circ Physiol 267: H215–H223Google Scholar
- Study Group on Experimental Arrhythmia Research of the Working Group on Arrhythmias of the European Society of Cardiology (1995) The role of basic arrhythmia research: the continued need for experiments in the intact heart and organism. Eur Heart J 16: 1469–1475Google Scholar
- Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology (1996) Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93: 1043–1065Google Scholar
© Springer-Verlag Berlin Heidelberg 2005